VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies. uri icon

authors

  • Beaton, Laura
  • Hague, Julian
  • Sharma, Dinesh
  • Pollok, Joerg-Matthias
  • Davidson, Brian R
  • Raja, Jowad
  • Munneke, Graham
  • Stuckey, Daniel J
  • Bascal, Zainab A
  • Wilde, Paul E
  • Cooper, Sarah
  • Tregidgo, Henry F J
  • Ryan, Samantha
  • Czuczman, Peter
  • Boucher, Eveline
  • Hartley, John A
  • Lewis, Andrew L
  • Jansen, Marnix
  • Meyer, Tim
  • Sharma, Ricky A
  • Znati, Sami A
  • Forsyth, Sharon
  • Clarkson, Matthew J
  • Bandula, Steven
  • Chouhan, Manil
  • Lowe, Helen L
  • Zaw Thin, May

publication date

  • January 1, 2019